Amarantus BioScience Holdings, Inc. Stock
Equities
AMBS
US02300U2050
Biotechnology & Medical Research
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | 0.00% | 0.00% | -80.00% |
Financials (USD)
Sales 2014 | - | Sales 2015 | - | Capitalization | 8.57M |
---|---|---|---|---|---|
Net income 2014 | -27M | Net income 2015 | -25M | EV / Sales 2014 | - |
Net cash position 2014 | 89K | Net Debt 2015 | 2.96M | EV / Sales 2015 | - |
P/E ratio 2014 |
-2.06
x | P/E ratio 2015 |
-0.15
x | Employees | 12 |
Yield 2014 * |
-
| Yield 2015 |
-
| Free-Float | 100% |
3 months | -66.67% | ||
6 months | -80.00% | ||
Current year | -80.00% |
Managers | Title | Age | Since |
---|---|---|---|
Founder | 79 | 08-01-13 | |
Founder | 41 | 08-01-13 | |
Donald Huffman
CEO | Chief Executive Officer | 77 | 14-07-21 |
Members of the board | Title | Age | Since |
---|---|---|---|
Donald Huffman
CEO | Chief Executive Officer | 77 | 14-07-21 |
Founder | 79 | 08-01-13 | |
Founder | 41 | 08-01-13 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-08 | 0.0001 | 0.00% | 200 |
24-05-07 | 0.0001 | 0.00% | 20,801 |
24-05-03 | 0.0001 | 0.00% | 8,267 |
Delayed Quote OTC Markets, May 08, 2024 at 12:12 pm EDT
More quotes1st Jan change | Capi. | |
---|---|---|
-80.00% | 63.04K | |
+23.37% | 47.02B | |
+50.01% | 41.86B | |
-0.94% | 41.76B | |
-4.32% | 28.8B | |
+11.29% | 26.05B | |
-20.92% | 19.15B | |
+3.20% | 12.55B | |
-2.67% | 11.82B | |
+30.23% | 12.34B |
- Stock Market
- Equities
- AMBS Stock